Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 29,382	$ 18,214	$ 73,203	$ 39,276
General and administrative	7,299	6,362	22,014	15,807
Total operating expenses	36,681	24,576	95,217	55,083
Loss from operations	(36,681)	(24,576)	(95,217)	(55,083)
Interest income	1,370	22	2,471	70
Other expense, net	(9)	(12)	(27)	(12)
Net loss	$ (35,320)	$ (24,566)	$ (92,773)	$ (55,025)
Net loss per share, basic	$ (0.87)	$ (0.61)	$ (2.28)	$ (1.37)
Net loss per share, diluted	$ (0.87)	$ (0.61)	$ (2.28)	$ (1.37)
Weighted-average shares of common stock used to compute net loss per shares, basic	40,747,026	40,396,188	40,684,172	40,234,159
Weighted-average shares of common stock used to compute net loss per shares, diluted	40,747,026	40,396,188	40,684,172	40,234,159